Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional status.
about
Radiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for N2-3 nasopharyngeal cancer: a multicenter trial of the Forum for Nuclear Cooperation in AsiaProphylactic feeding tubes for patients with locally advanced head-and-neck cancer undergoing combined chemotherapy and radiotherapy-systematic review and recommendations for clinical practice.Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma.Phase III study of radiation therapy with or without cis-platinum in patients with unresectable squamous or undifferentiated carcinoma of the head and neck: an intergroup trial of the Eastern Cooperative Oncology Group (E2382).Treatment outcome of cisplatin-based concurrent chemoradiotherapy in the patients with locally advanced nasopharyngeal cancer.Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinomaEfficacy and tolerability of weekly low-dose cisplatin concurrent with radiotherapy in head and neck cancer patients.Cancer cachexia update in head and neck cancer: Definitions and diagnostic features.Phase IIb trial comparing two concurrent cisplatin schedules in locally advanced head and neck cancer.Importance of maintaining body weight for prevention of distant metastasis of nasopharyngeal carcinoma: An alternative workflow for cancer-risk assessment.Predictive single nucleotide polymorphism markers for acute oral mucositis in patients with nasopharyngeal carcinoma treated with radiotherapy.Patient preferences for oropharyngeal cancer treatment de-escalation.
P2860
Q34494991-89491A65-1D6D-45FA-B9CC-4F129F5C8BABQ35145692-46175356-15A2-468C-95A4-24A7060A7380Q36407458-96D18C01-041B-4545-9412-0114E15677E3Q36730781-CD41262A-DE2A-40DE-BFFF-9EFF63D7DF72Q37230165-A6F51BB3-4BCC-4A7F-AC0B-C73C4A061217Q37407412-E1B3F669-2BB3-499B-ADBF-5BA8DB754526Q37925136-83F01B47-7892-45F8-97C2-D6AEA7723848Q38177750-42EF5CD2-1053-408E-9C41-F3BF69AA110BQ40124912-9AA6B34B-6DF8-4265-83E5-A16DE8E89A5FQ41441035-0BD80987-624D-4232-B84A-02EADAA07543Q42179302-776C4FA5-CA0A-4398-9529-2F8ECF82BCBEQ45378293-99B163B4-6989-406E-821C-549160093694
P2860
Tolerability of the Intergroup 0099 (INT 0099) regimen in locally advanced nasopharyngeal cancer with a focus on patients' nutritional status.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Tolerability of the Intergroup ...... patients' nutritional status.
@ast
Tolerability of the Intergroup ...... patients' nutritional status.
@en
type
label
Tolerability of the Intergroup ...... patients' nutritional status.
@ast
Tolerability of the Intergroup ...... patients' nutritional status.
@en
prefLabel
Tolerability of the Intergroup ...... patients' nutritional status.
@ast
Tolerability of the Intergroup ...... patients' nutritional status.
@en
P2093
P50
P1476
Tolerability of the Intergroup ...... patients' nutritional status.
@en
P2093
Andrew Bayley
Bernard J Cummings
Betty Lemon
Eric X Chen
Gregory R Pond
Ian F Tannock
Leah Gitterman
Lillian L Siu
P304
P356
10.1016/J.IJROBP.2004.05.011
P407
P577
2004-11-01T00:00:00Z